Multicenter preclinical validation of next-generation CAR T cells: a strategy for harmonization, reproducibility, and its feasibility in clinical translation
Iman Dalloul, Markus Barden, Juliane C. Wilcke, Sophie Bernhard, Nicole Ellenbach, Anne‐Laure Boulesteix, Hinrich Abken, Sebastian Kobold
This paper validates a multicenter preclinical strategy for CAR T cells, demonstrating its feasibility in confirming CCR8 overexpression benefits across multiple centers.
bioRxiv · Apr 10, 2026 · PreprintSynthetic Biology